Novo Nordisk plans price cuts for several insulins
![](https://ktvz.com/wp-content/uploads/2019/10/ktvz-biz-tech.png)
By TOM MURPHY
AP Health Writer
Another major insulin maker has promised steep price cuts, as pressure grows on drugmakers and insurers to trim the cost of a medication that millions of Americans need. Novo Nordisk said Tuesday that it will slash some of its U.S. insulin prices up to 75% starting next year. The announcement comes less than two weeks after rival Eli Lilly said it will drop some of its prices by 70% or more later this year. Diabetes care experts say cuts on the initial prices drugmakers charge are only a step toward making insulin more widely affordable.